Background: Restless legs syndrome (RLS) is a common sleep disorder in which urges to move the legs are felt during rest, are felt at night, and are improved by leg movement. RLS has been implicated in the development of cardiovascular disease. Periodic leg movements (PLMs) may be a mediator of this relationship. We evaluated systemic inflammation and PLMs in RLS patients to further assess cardiovascular risk. Methods: 137 RLS patients had PLM measurements taken while unmedicated for RLS. Banked plasma was assayed for high sensitivity C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha). Results: Mean (SD) PLM index was 19.3 (22.0). PLMs were unrelated to TNF-a and IL-6, but were modestly correlated with log CRP (r(129) = 0.19, p = 0.03). Those patients with at least 45 PLMs/h had an odds ratio of 3.56 (95% CI 1.26-10.03, p = 0.02, df = 1) for having elevated CRP compared to those with fewer than 45 PLMs/h. After adjustment for age, race, gender, diabetes, hypertension, hyperlipidemia, inflammatory disorders, CRP-lowering medications, and body mass index, the OR for those with P45 PLMs/h was 8.60 (95% CI 1.23 to 60.17, p = 0.03, df = 10). Conclusions: PLMs are associated with increased inflammation, such that those RLS patients with at least 45 PLMs/h had more than triple the odds of elevated CRP than those with fewer PLMs. Further investigation into PLMs and inflammation is warranted.
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Introduction
Restless legs syndrome (RLS) is a common sleep disorder in which urges to move the legs are bothersome during rest and at night, and are improved by leg movement. In addition to sensory symptoms, the majority of RLS patients also experience periodic leg movements (PLMs). PLMs are repetitive movements occurring every 5-90 s. Over 90% of RLS patients demonstrate at least 5 PLMs/h when monitored by leg actigraphy for five nights (Trotti et al., 2009) .
Both RLS and PLMs have been implicated in the development of cardiovascular disease. RLS has been shown to be associated with prevalent cardiovascular disease in several large population-based studies (Innes et al., 2012) . PLMs, either in association with RLS or as an isolated finding, have been associated with changes in heart rate and heart rate variability (Ferri et al., 2007; Guggisberg et al., 2007; Manconi et al., 2011; Sforza et al., 2005) , beat to beat increases in blood pressure (Pennestri et al., 2007; Siddiqui et al., 2007a) , and prevalent hypertension (Billars et al., 2007) , and predict incident vascular events in elderly normotensive men (Koo et al., 2011) .
RLS is strongly associated with systemic inflammation, in that nearly 90% of the medical conditions known to be associated with RLS are inflammatory or infectious (Weinstock et al., 2012) , and systemic inflammation is associated with and predictive of cardiovascular disease (Casas et al., 2008; Danesh et al., 2008; Libby, 2006; Sarwar et al., 2009; Venugopal et al., 2002; Yudkin et al., 2000; Zhang et al., 2009) . Systemic inflammation may be measured with a variety of markers, including C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-alpha). While these markers are known to be associated with other causes of sleep disruption, especially sleep apnea (Ciftci et al., 2004; Jelic et al., 2008; Ryan et al., 2006; Shamsuzzaman et al., 2002; Steiropoulos et al., 2010; Svatikova et al., 2003; Vgontzas et al., 1997) and chronic partial sleep deprivation (Lange et al., 2010), they have not been evaluated with respect to PLMs in RLS patients.
